Combined Nerve and Tendon Transfer for the Restoration of Hand Function in Individuals With Tetraplegia ([CNaTT])
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04276181 |
Recruitment Status :
Not yet recruiting
First Posted : February 19, 2020
Last Update Posted : August 5, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Spinal Cord Injury Cervical Tendon Transfer Nerve Transfer Rehabilitation Grip Function |

Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 80 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 1 Year |
Official Title: | Combined Nerve and Tendon Transfer for the Restoration of Hand Function in Individuals With Tetraplegia |
Estimated Study Start Date : | October 2020 |
Estimated Primary Completion Date : | December 31, 2023 |
Estimated Study Completion Date : | December 31, 2023 |
Group/Cohort |
---|
CNaTT
The surgical procedures are described in the section Detailed description
|
- Cylinder test [ Time Frame: 5 minutes ]This test is developed at SUH and currently under reliability testing. The cylinder test assesses the patients' ability to actively grasp and release glass cylinders of varying breadth, ranging from 10 to 150 mm.
- Grip ability as measured using the Grasp and Release Test (GRT) [ Time Frame: 20 minutes ]GRT assesses the ability to pick up, move, and release six objects of varying sizes, weights and textures using a palmar or lateral grasp. Each object represents one or more objects routinely manipulated for activities of daily living (ADL) that represented a range of difficulties.
- Grip strength will be measured with JAMAR dynamometer [ Time Frame: 2 minutes ]
- Pinch grip strength will be assessed using the Pinch Gauge [ Time Frame: 2 minutes ]
- Activity and participation (goal achievement and quality of life) will be measured using the Canadian Occupational Performance Measure (COPM) [ Time Frame: 10 minutes ]
- Activity and participation will be measured using the Tetraplegic Upper Limb Activity Questionnaire (TUAQ). [ Time Frame: 10 minutes ]Ranges between 13 to 130. Lower scores indicate a higher level of independence.
- Satisfaction with surgery will be measured using the Swedish tetraplegia surgery satisfaction questionnaire. [ Time Frame: 10 minutes ]Ranges between 20 - 100. Higher scores indicate a higher level of satisfaction

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 15 Years to 55 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion criteria:
- Subjects must be between 15-55 years of age
- Subjects must be diagnosed with a spinal cord injury AIS level C5 to C7
- Time after injury ≤ 12 months
- The strength of the muscle supplied by the donor nerve (supinator) must be graded ≥ 4 according to Medical Research Council (MRC)
- The strength of musculus brachioradialis and wrist extensors must be graded ≥ 4 according to MRC (to be used in grip reconstruction)
Exclusion criteria:
- Finger extensor strength ≤ MRC 1
- Evidence of lower motor neuron injury in muscles supplied by the donor nerve
- Subjects must not have any current serious or unstable illness that could interfere with the study
- Medically unstable to undergo surgery as determined by physician
- Spasticity in the forearm or hand graded > 1 according to Modified Ashworth Scale

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04276181
Contact: Lina Bunketorp-Käll, PhD | +46709723101 ext +46709723101 | lina.bunketorp-kall@neuro.gu.se |
Responsible Party: | Lina Bunketorp Kall, Principal Investigator, Göteborg University |
ClinicalTrials.gov Identifier: | NCT04276181 |
Other Study ID Numbers: |
ALFGBG-918031 ALFGBG-774951 ( Other Grant/Funding Number: the Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement ) |
First Posted: | February 19, 2020 Key Record Dates |
Last Update Posted: | August 5, 2020 |
Last Verified: | August 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Spinal Cord Injuries Quadriplegia Spinal Cord Diseases Central Nervous System Diseases Nervous System Diseases |
Trauma, Nervous System Wounds and Injuries Paralysis Neurologic Manifestations |